Equity-Based Compensation (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Summary of Nonvested Stock Units Activity |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
Unvested at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at end of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
Unvested at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at end of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
|
|
Weighted Average
Grant Date
Fair Value
|
|
Unvested at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at end of period |
|
|
|
|
|
|
|
|
|
|
| Summary of Stock Options Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
|
|
|
|
|
|
|
Incentive Options
Weighted Average
Exercise Price
|
|
Outstanding at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period |
|
|
|
|
|
|
|
|
|
1 As the Reload and Staking Options were one-time grants at the IPO, the weighted-average exercise price for any
movements in these awards will perpetually be $23.50. As such, the values are not presented in the table above.
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2026 |
|
|
|
Reload Class C
Incentive Units
|
|
Staking Class C
Incentive Units
|
|
|
|
Class C Incentive
Units Weighted
Average
Participation
Threshold
|
|
Unvested at beginning of period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at end of period |
|
|
|
|
|
|
|
|
|
|
| Summary of Aggregate Intrinsic Values and Weighted Average Remaining Contractual Terms of Stock Options Outstanding and Exercisable |
The aggregate intrinsic values and weighted-average remaining contractual terms of Stock Options
outstanding and exercisable as of March 31, 2026, were as follows:
|
|
|
Aggregate intrinsic value ($ in thousands): |
|
|
Reload Options outstanding |
|
|
Reload Options exercisable |
|
|
Staking Options outstanding |
|
|
Staking Options exercisable |
|
|
Incentive Options outstanding |
|
|
Incentive Options exercisable |
|
|
Weighted-average remaining contractual term (in years): |
|
|
Reload Options outstanding |
|
|
Reload Options exercisable |
|
|
Staking Options outstanding |
|
|
Staking Options exercisable |
|
|
Incentive Options outstanding |
|
|
Incentive Options exercisable |
|
|
|
| Summary of Recognized and Unrecognized Equity-Based Compensation Costs |
The following table includes the equity-based compensation the Company recognized by award type:
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
|
|
|
|
|
|
IPO RSUs and Staking Options |
|
|
|
|
IPO RLUs and Staking Class C Incentive Units |
|
|
|
|
Incremental Restricted Stock and Reload Options |
|
|
|
|
Incremental Restricted Common Units and Reload Class C Incentive Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post-IPO incentive awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity-based compensation expense |
|
|
|
|
As of March 31, 2026, the unrecognized equity-based compensation expense and the related weighted-average remaining
expense period, as applicable, related to the types of equity-based compensation awards described above were as follows:
|
|
|
|
|
|
|
|
Weighted Average
Remaining Expense
Period (Years)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reload Class C Incentive Units |
|
|
|
|
Staking Class C Incentive Units |
|
|
|
|
|
|
|
|
|
Total unrecognized equity-based compensation expense |
|
|
|
|
|